The Carlyle Group's SWOT analysis: stock outlook amid market volatility

Carlyle Group (CG) reported Q4 2024 after-tax Distributable Earnings of $0.92 per share, slightly below estimates, but maintains strong fundamentals with a 20% return on equity. While AUM experienced a slight decline, fundraising remained robust at $41 billion for the year, and the company projects 6% FRE growth for 2025. Despite mixed investment performance across segments and sensitivity to market volatility (beta of 1.84), analysts have price targets ranging from $43 to $62, reflecting the potential for upside amid a growing alternative asset management sector.

Analysis

The Carlyle Group Inc. (CG) reported fourth-quarter 2024 after-tax Distributable Earnings (DE) of $0.92 per share, falling slightly short of the $0.95 estimate and $0.96 consensus due to diminished realizations and fee-related earnings (FRE). Despite this, the company maintains robust fundamentals, evidenced by a 20% return on equity and a P/E ratio of 14.6x, with InvestingPro analysis suggesting an undervaluation at its $44.27 trading price. Assets Under Management (AUM) and fee-earning AUM saw a minor decrease attributed to realizations, outflows, market activity, and currency headwinds. However, Carlyle demonstrated strong fundraising capabilities, securing $14 billion in Q4 and achieving a $41 billion total for the full year. Investment performance varied, with Credit and Investment Solutions appreciating 3% while Global Private Equity grew 1%. For 2025, management projects a "base case" 6% year-over-year FRE growth, with a consistent fundraising target of $41 billion. The alternative asset management sector, where Carlyle is a prominent player, has shown significant growth, with Carlyle itself posting a 127% revenue increase in the last twelve months. The company's beta of 1.84 indicates higher market sensitivity, which could offer greater upside in favorable conditions but also poses risks. A key strength is the $2.74 billion in net accrued performance fees, up 15% year-over-year, signaling potential for future realizations, and management remains optimistic about the health of its portfolio companies. InvestingPro assigns Carlyle a 'FAIR' Financial Health Score of 2.41. Analyst earnings per share estimates for 2025 and 2026 are $4.35 and $4.90 respectively, reflecting a tempered outlook, with price targets ranging from $43.00 to $62.00. Challenges include navigating market volatility, meeting ambitious fundraising targets amidst recent reported misses, and justifying high industry valuation multiples.

Key Decisions for Investors

• Investors might consider Carlyle's current valuation potentially attractive given its strong fundraising, $2.74 billion in net accrued performance fees, and healthy portfolio, but should balance this against recent earnings misses and AUM pressures linked to market volatility.
• Monitor Carlyle's progress towards its 2025 targets, particularly the 6% FRE growth projection and the $41 billion fundraising goal, as achieving these will be crucial for validating its growth narrative and supporting its valuation in a competitive market.
• Factor Carlyle's high beta of 1.84 into risk assessments, recognizing its heightened sensitivity to market fluctuations, which could amplify both gains in positive markets and losses in downturns.
• Evaluate the company's ability to capitalize on opportunities within the growing alternative asset sector, such as deploying capital at attractive valuations during market dislocations and converting its optimistic outlook on portfolio companies into tangible distributable earnings.